Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.29
+1.11%
Mkt Cap $482.39M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
Implied Upside
+140.7%
Consensus $5.50 vs current $2.29
NASDAQ·Healthcare·Biotechnology
$2.29
+1.11%
Mkt Cap $482.39M
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
+140.7%
Consensus $5.50 vs current $2.29